ABBV vs ARDT · P/E 81, rev $16.99B vs P/E 8.5, rev $6.32B
AbbVie Inc (ABBV) versus Ardent Health Partners, Inc. (ARDT) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Ardent Health Partners, Inc. (ARDT) is a medical care facilities company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ARDT revenue for 2025-12-31 was $6.32B. Net income was $135.8M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. ARDT currently screens at market cap $2.10B and trailing P/E 8.5.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ARDT currently screens at market cap $2.10B and trailing P/E 8.5.
Not investment advice. Open the ABBV and ARDT stock pages for the full models.
Not investment advice.